One study determined that ZNF217 mediated collagen matrix abundance-induced AKT activation and mammary epithelial cell proliferation, and triciribine could potentially be utilized as a chemo-preventive agent to decrease the risk of breast cancer for females identified as having enhanced mammographic density [22]. The gene discussed is AKT1; the disease is breast carcinoma.